Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours.
about
The effect of antineoplastic drugs in a male spontaneous mammary tumor modelERbeta in breast cancer--onlooker, passive player, or active protector?Isoflavones are safe compounds for therapeutical applications - evaluation of in vitro data.Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer.The mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-α in human breast tumors in vivo.Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role?Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer.ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approachesERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancerEstrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.Claudin 1 expression in basal-like breast cancer is related to patient ageCARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.Triple-negative breast cancer: new perspectives for targeted therapies.Estrogen receptor β ligands: recent advances and biomedical applications.Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifenEstrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells.PKCα and ERβ Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients.Estrogen receptor-beta and breast cancer: translating biology into clinical practicePrognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer.Identification of Claudin 1 Transcript Variants in Human Invasive Breast Cancer.Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomasExpression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancersDevelopment, characterization, and applications of a novel estrogen receptor beta monoclonal antibody.Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes.Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cellsSex hormone receptor repertoire in breast cancer.Lack of functional TSLP receptors mitigates Th2 polarization and the establishment and growth of 4T1 primary breast tumours but has different effects on tumour quantities in the lung and brain.Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patientsDifferential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer.Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.Serum estrogen receptor bioactivity and breast cancer risk among postmenopausal womenIntegrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators.Triple-negative breast cancer: investigating potential molecular therapeutic target.Ki-67 evaluation at the hottest spot predicts clinical outcome of patients with hormone receptor-positive/HER2-negative breast cancer treated with adjuvant tamoxifen monotherapy.Role of ER-α36 in breast cancer by typical xenoestrogens.Steroid hormone receptors as prognostic markers in breast cancer.ERα and ERβ co-expression: An indicator of aggressive tumors and hormonal sensitivity.
P2860
Q28533591-61ED3871-D942-4D6A-BB89-C04F7186B620Q30438399-131D2686-8499-4036-B5F7-9C7F8BA899B6Q33480555-51436A2F-76F6-4D4B-B44E-776719FCAFF6Q33632616-64A0DE5C-3C7A-4F28-94F8-46E8939E4C63Q33800419-14967B31-2B50-4602-8818-59D8BCA95727Q33827011-09B47F27-9B7F-4BFF-BB8C-D92AF756D732Q33856461-4EEFE4C5-4219-43EF-B5FA-ED25F39C6246Q33866151-2F7CF770-DD03-414E-A1DD-E3C81B43F348Q33989940-EE7F756A-D1E7-424C-8905-E729BE3A3031Q34119028-C0D47CA6-8623-4189-89C6-AA1FD6920B8AQ34334131-E5ACC1DE-4E83-4017-B4E8-D46A38290E7AQ34663257-6A37429E-52D8-42DE-B908-8935F3022C0AQ34747887-24CEF878-A297-4110-AA04-C5E76BB77E27Q34794245-B997C123-B813-4E0A-BEE3-C34C6857AB98Q35001758-B18564BF-DEAF-43F6-86DD-ED911FB51306Q35016384-4B425FC7-95AA-495E-A779-A1E307BCB2CFQ35271188-E952F762-9544-4897-8843-74A02DDF6F5DQ35558946-CF8D812D-BD48-4947-B93E-43F2B997534EQ35585091-86348A51-9036-408F-936B-C2624B76CD21Q35821415-8267C39A-7D52-4350-AB4A-55361FD83761Q35973424-4570F924-D73D-42E0-A8CB-34B0A67179BBQ35993074-885F911D-9545-43D5-8BF7-F37BF4547BD7Q36138531-22B7A32B-67F9-4124-ABC3-F10D0084FC89Q36251310-16121FEE-9CEA-4F8E-B8CB-039D1ECBD008Q36477512-ED970D36-279B-4369-A1BE-7E8F9DA7E0A7Q37049590-5F6354BE-8527-4AA4-97BB-F9503B85DBFCQ37153775-A1FD9D8E-DF2E-4C46-939D-84B773D287E7Q37207621-F5AD840C-A7BD-485D-B5FD-40029558E825Q37353645-A315CF3A-C122-40DF-A22D-CB21A1341484Q37358435-6758E544-3647-4CA3-9B46-63ABE0B74329Q37467175-C1590648-1EE1-48A7-9F33-F61BD61D0C2FQ37571359-461AF146-C7C3-4602-BFFB-0DF1B315C5DAQ37636714-D6521E9F-70B8-4CCD-97DF-F44A10C16B93Q37656401-1725F6C7-DD44-41FB-A0ED-169DCE89F43CQ37660496-8B45282F-B0AE-488D-9321-48D05C104BAEQ38259322-84EAF2CF-4336-4C61-8DF0-698BC8AEE88FQ38397819-2293AB59-6520-46C7-AD0C-E5CAB8F5A7D0Q38580235-992C24E8-8D16-4A12-98F1-F13E3B850D51Q38598704-5D4C7E50-63F3-49B2-AD24-3C8FAF63068CQ38624809-24EEDA2F-8A24-42E7-AB98-5ABF66FE18D1
P2860
Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Expression of oestrogen recept ...... negative human breast tumours.
@ast
Expression of oestrogen recept ...... negative human breast tumours.
@en
type
label
Expression of oestrogen recept ...... negative human breast tumours.
@ast
Expression of oestrogen recept ...... negative human breast tumours.
@en
prefLabel
Expression of oestrogen recept ...... negative human breast tumours.
@ast
Expression of oestrogen recept ...... negative human breast tumours.
@en
P2093
P2860
P356
P1476
Expression of oestrogen recept ...... negative human breast tumours.
@en
P2093
G P Skliris
L Curtis-Snell
P H Watson
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603295
P407
P577
2006-08-01T00:00:00Z